{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:53:08Z","timestamp":1787017988124,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2005,2,8]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Tamoxifen, a selective estrogen-receptor modulator, increases venous thromboembolic events (VTE), but the factors explaining this risk are unclear. Atherosclerosis may induce VTE, or the 2 conditions may share common risk factors. We assessed the effect of tamoxifen on VTE in a breast cancer prevention trial and studied its association with risk factors for VTE.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods and Results\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    The incidence of VTE was studied in 5408 hysterectomized women randomly assigned to tamoxifen 20 mg\/d or placebo for 5 years. There were 28 VTEs on placebo and 44 on tamoxifen therapy (hazard ratio [HR]=1.63; 95% confidence interval [CI], 1.02 to 2.63), 80% of which were superficial phlebitis, accounting for all of the excess due to tamoxifen within 18 months from randomization. Compared with placebo, the risk of VTE on tamoxifen was higher in women aged 55 years or older, women with a body mass index \u226525 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    , elevated blood pressure, total cholesterol \u2265250 mg\/dL, current smoking, and a family history of coronary heart disease (CHD). Of the 685 women with a CHD risk score \u22655 who entered the trial, 1 in the placebo arm and 13 in the tamoxifen arm developed VTE (log-rank\n                    <jats:italic>P<\/jats:italic>\n                    =0.0013). In multivariate regression analysis, age \u226560 years, height \u2265165 cm, and diastolic blood pressure \u226590 mm Hg had independent detrimental effects on VTE risk during tamoxifen therapy, whereas transdermal estrogen therapy concomitant with tamoxifen was not associated with any excess of VTE (HR=0.64; 95% CI, 0.23 to 1.82).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusions\u2014<\/jats:italic>\n                    <\/jats:bold>\n                    Women with conventional risk factors for atherosclerosis have a higher risk of VTE during tamoxifen therapy. This information should be incorporated into counseling women on its risk-benefit ratio, particularly in the prevention setting.\n                  <\/jats:p>","DOI":"10.1161\/01.cir.0000154545.84124.ac","type":"journal-article","created":{"date-parts":[[2005,2,7]],"date-time":"2005-02-07T18:28:13Z","timestamp":1107800893000},"page":"650-656","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":132,"title":["Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial"],"prefix":"10.1161","volume":"111","author":[{"given":"Andrea","family":"Decensi","sequence":"first","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maisonneuve","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rotmensz","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Bettega","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Costa","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Sacchini","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Salvioni","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Travaglini","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Oliviero","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D\u2019Aiuto","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Gulisano","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Gucciardo","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Rosselli","family":"del Turco","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Pizzichetta","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafino","family":"Conforti","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Boyle","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Veronesi","sequence":"additional","affiliation":[{"name":"From the Divisions of Chemoprevention (A.D., B.B.), Epidemiology and Biostatistics (P.M., N.R., P.B.), and Senology (V.S., U.V.), European Institute of Oncology, Milan, Italy; Department of Medical and Preventive Oncology (A.D.), Ospedali Galliera, Genoa, Italy; Ospedale Moriggia Pelascini (D.B.), Gravedona, Italy; and Fondazione Maugeri (A.C.), Pavia, Italy; Memorial Sloan-Kettering Cancer Center (V.S.), New York, NY; Centro Cardiologico Monzino (A.S.), Milan, Italy; Comitato Prevenzione Tumori (R..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12342-2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1371"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.11.2758"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.111"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022157"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540320044033"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03563.x"},{"key":"e_1_3_2_9_2","first-page":"689","volume":"132","year":"2000","unstructured":"Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the Heart and Estrogen\/progestin Replacement Study. Ann Intern Med. 2000; 132: 689\u2013696.","journal-title":"Ann Intern Med"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.11.1405"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85011-3"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.2.160"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.97.18.1837"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc B. 1972; 34: 187\u2013220.","journal-title":"J R Stat Soc B"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_3_2_16_2","unstructured":"Garber JE Costantino JP Wickerham DL Berliner N Wolmark N. Factor V Leiden (FVL) and prothrombin G20210A (PTG) mutations and risk of thromboembolic events (TE) in NSABP P-1 the breast cancer prevention trial (BCPT). Presented at: 25th Annual San Antonio Breast Cancer Symposium; December 11-14 2002; San Antonio Tex. Abstract No. 413."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-9-200205070-00011"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616237"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32312"},{"key":"e_1_3_2_20_2","first-page":"409","volume":"1","year":"1982","unstructured":"Lowe GD, Osborne DH, McArdle BM, Smith A, Carter DC, Forbes CD, McLaren D, Prentice CR. Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery. Lancet. 1982; 1: 409\u2013412.","journal-title":"Lancet"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960231103"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657540"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.21.10.1701"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.23.2189"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.2.216"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg022"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7305.131"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09962-2"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14066-4"},{"key":"e_1_3_2_30_2","first-page":"1610.","volume":"354","year":"1999","unstructured":"Poulter NR, Chang CL, Farley TM, Meirick O. Risk of cardiovascular diseases associated with oral progestogen preparations with therapeutic indications. Lancet. 1999; 354: 1610.","journal-title":"Lancet"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-55647-0_10"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000154545.84124.AC","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T08:55:48Z","timestamp":1715504148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000154545.84124.AC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,2,8]]}},"alternative-id":["10.1161\/01.CIR.0000154545.84124.AC"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000154545.84124.ac","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,8]]},"assertion":[{"value":"2005-02-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}